CLINICAL_TRIALS
trial_result
· 2023-01-17
Clinical Trial Update: Open-label Extension to Protocol 1042-0600 [Phase 2]
Summary
Open-label extension study update for a Phase 2 trial in partial epilepsies; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Marinus Pharmaceuticals | Conditions: Epilepsies, Partial | Phase 2 | Status: COMPLETED | Results posted: 2023-01-17